Brief: Lee's Pharmaceutical Holdings Limited Acquires Staccato One Breath Technology Platform And Assets, Driving Pipeline Expansion And Advancing Global Partnership With UCB Through Acquired Rights
09/12/2025 13:04
Dec 9 (Reuters) - Lee's Pharmaceutical Holdings Ltd 0950.HK: LEE'S PHARMACEUTICAL HOLDINGS LIMITED ACQUIRES STACCATO® ONE BREATH TECHNOLOGY® PLATFORM AND ASSETS, DRIVING PIPELINE EXPANSION AND ADVANCING GLOBAL PARTNERSHIP WITH UCB THROUGH ACQUIRED RIGHTS LEE'S PHARMACEUTICAL HOLDINGS LTD: CO TOGETHER WITH NPI MAY RECEIVE MILESTONE PAYMENTS TOTALLING UP TO US$60.5 MILLION Source text: ID:nPn8wCPLqa Further company coverage: 0950.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA